1. Home
  2. EVER vs IVA Comparison

EVER vs IVA Comparison

Compare EVER & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

N/A

Current Price

$24.60

Market Cap

928.5M

Sector

Technology

ML Signal

N/A

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

N/A

Current Price

$4.68

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVER
IVA
Founded
2008
2011
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
928.5M
1.1B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
EVER
IVA
Price
$24.60
$4.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
$27.00
$16.20
AVG Volume (30 Days)
737.6K
781.4K
Earning Date
05-04-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
198.86
N/A
EPS
1.04
N/A
Revenue
$163,349,000.00
N/A
Revenue This Year
$14.73
N/A
Revenue Next Year
$11.51
$751.20
P/E Ratio
$24.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$3.35
52 Week High
$28.73
$7.98

Technical Indicators

Market Signals
Indicator
EVER
IVA
Relative Strength Index (RSI) 48.22 58.58
Support Level $24.31 $4.11
Resistance Level $27.56 $6.15
Average True Range (ATR) 1.36 0.21
MACD -0.24 0.01
Stochastic Oscillator 42.44 72.22

Price Performance

Historical Comparison
EVER
IVA

About EVER EverQuote Inc.

EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: